肝硬化相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Sex‑specific trends and demographic vs. epidemiologic drivers of alcohol‑related cirrhosis in United States, 2021-2040: Letter to the editor on "Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United States"

2021-2040 年美国酒精相关性肝硬化的性别特定趋势及人口统计学与流行病学驱动因素：致编辑的信，主题为“美国酒精相关性肝病中的性别差异和酒精相关癌症的亚型差异”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0790

Wang, Kui; Zeng, Yunqing

发表日期：2026

文献求助收藏

Letter to the editor on "Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis"

致编辑的信，主题为“Baveno VI-SSM 对 HBV 相关肝硬化患者门静脉高压相关事件的风险进行分层”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0521

Zheng, Bo; Wang, Lizhou

发表日期：2026

文献求助收藏

Correspondence to letter to the editor on "Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis"

致编辑的信函，主题为“Baveno VI-SSM 对 HBV 相关肝硬化患者门静脉高压相关事件的风险进行分层”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0611

Wang, Haiyu; Chen, Jinjun

发表日期：2026

文献求助收藏

Correspondence to editorial on "Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation"

致编辑的信函，主题为“急性失代偿期肝硬化患者中人巨细胞病毒的再激活”

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0899

Hong, Changze; Chen, Jinjun

细胞生物学

发表日期：2026

文献求助收藏

Human cytomegalovirus reactivation in decompensated cirrhosis: marker of immunosuppression or contributor to severity?: Editorial on "Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation"

失代偿期肝硬化患者中人巨细胞病毒再激活：是免疫抑制的标志还是加重病情的因素？：关于“急性失代偿期肝硬化患者中人巨细胞病毒再激活”的社论

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0962

Cao, Zhujun; Moreau, Richard

免疫/内分泌

细胞生物学

发表日期：2026

文献求助收藏

Burden of malnutrition and sarcopenia in patients with cirrhosis: pathophysiology, assessment, and management

肝硬化患者营养不良和肌肉减少症的负担：病理生理学、评估和管理

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.1126

Miwa, Takao; Shimizu, Masahito; Schnabl, Bernd

发表日期：2026

文献求助收藏

Refining portal hypertension assessment: The clinical significance of spleen stiffness measurement in the Baveno VII Era: Editorial on "Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis"

完善门静脉高压评估：Baveno VII 时代脾脏硬度测量的临床意义：关于“Baveno VI-SSM 对 HBV 相关肝硬化患者门静脉高压相关事件风险进行分层”的社论

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0296

发表日期：2026

文献求助收藏

Clinical implications of residual changes following HCV clearance: Editorial on "Distinct inflammatory imprint in non-cirrhotic and cirrhotic patients before and after direct-acting antiviral therapy"

丙型肝炎病毒清除后残留改变的临床意义：关于“直接抗病毒治疗前后非肝硬化和肝硬化患者不同的炎症印记”的社论

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0728

Kim, So-Young; Shin, Eui-Cheol

发表日期：2026

文献求助收藏

Call for preemptive treatment of cytomegalovirus in patients with cirrhosis and acute decompensation: Editorial on "Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation"

呼吁对肝硬化和急性失代偿期患者进行巨细胞病毒预防性治疗：关于“肝硬化急性失代偿期患者中人巨细胞病毒再激活”的社论

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0840

细胞生物学

发表日期：2026

文献求助收藏

Predicting decompensation risk in compensated HBV cirrhosis: Eternal sunshine for a spotless mind?: Editorial on "Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis"

预测代偿期乙肝病毒肝硬化失代偿风险：完美无瑕的头脑永远沐浴在阳光下？：关于“Baveno VI-SSM 对乙肝病毒相关肝硬化患者门静脉高压相关事件风险进行分层”的社论

期刊:Clinical and Molecular Hepatology

影响因子:16.9

doi:10.3350/cmh.2025.0280

Jachs, Mathias; Mandorfer, Mattias

发表日期：2026

文献求助收藏